Related Experiment Video
Updated: May 29, 2025
Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Optogenetically Activatable MLKL as a Standalone Functional Module for Necroptosis and Therapeutic Applications in
Da-Hye Jeong1,2, Seokhwi Kim2,3, Han-Hee Park1,2
1Department of Biochemistry, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.
Abstract:
Necroptosis plays a crucial role in the progression of various diseases and has gained substantial attention for its potential to activate antitumor immunity. However, the complex signaling networks that regulate necroptosis have made it challenging to fully understand its mechanisms and translate this knowledge into therapeutic applications. To address these challenges, an optogenetically activatable necroptosis system is developed that allows for precise spatiotemporal control of key necroptosis regulators, bypassing complex upstream signaling processes. The system, specifically featuring optoMLKL, demonstrates that it can rapidly assemble into functional higher-order "hotspots" within cellular membrane compartments, independent of RIPK3-mediated phosphorylation. Moreover, the functional module of optoMLKL significantly enhances innate immune responses by promoting the release of iDAMPs and cDAMPs, which are critical for initiating antitumor immunity. Furthermore, optoMLKL exhibits antitumor effects when activated in patient-derived pancreatic cancer organoids, highlighting its potential for clinical application. These findings will pave the way for innovative cancer therapies by leveraging optogenetic approaches to precisely control and enhance necroptosis.
Insights
Researchers developed an optogenetic system to control necroptosis, a cell death pathway crucial for activating antitumor immunity. This novel approach enhances immune responses and shows promise for developing new cancer therapies.
Area of Science:
- Cellular Biology
- Immunology
- Biotechnology
Background:
- Necroptosis is a regulated form of cell death implicated in disease progression and antitumor immunity.
- Complex upstream signaling pathways regulating necroptosis hinder therapeutic development.
- Precise control over necroptosis is needed to harness its immunomodulatory potential.
Purpose of the Study:
- To develop an optogenetically activatable necroptosis system for precise spatiotemporal control.
- To investigate the assembly and function of optogenetically controlled MLKL (optoMLKL).
- To evaluate the potential of optoMLKL in enhancing antitumor immunity and its therapeutic applications.
Main Methods:
- Development of an optogenetically activatable necroptosis system featuring optoMLKL.
- Investigation of optoMLKL assembly into higher-order structures.
- Assessment of innate immune responses triggered by optoMLKL activation, including damage-associated molecular patterns (DAMPs) release.
- Testing of optoMLKL in patient-derived pancreatic cancer organoids.
Main Results:
- OptoMLKL rapidly assembled into functional hotspots within cellular membranes, independent of RIPK3 phosphorylation.
- OptoMLKL activation significantly enhanced innate immune responses through the release of intracellular and cellular damage-associated molecular patterns (iDAMPs and cDAMPs).
- Activated optoMLKL demonstrated antitumor effects in pancreatic cancer organoids.
Conclusions:
- Optogenetic control of necroptosis provides a powerful tool to bypass complex signaling networks.
- OptoMLKL effectively enhances innate immune responses and exhibits direct antitumor activity.
- This optogenetic approach holds significant potential for developing novel cancer immunotherapies.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
